Publikationen von Pjotr G. Knyazev

Xiao, Z.; Gaertner, S.; Morresi-Hauf, A.; Genzel, R.; Duell, T.; Ullrich, A.; Knyazev, P. G.: Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients. Neoplasia 19 (5), S. 385 - 395 (2017)

Sommer, A.-K.; Hermawan, A.; Mickler, F. M.; Ljepoja, B.; Knyazev, P.; Braeuchle, C.; Ullrich, A.; Wagner, E.; Roidl, A.: Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases. Oncotarget 7 (31), S. 50461 - 50476 (2016)

Gusenbauer, S.; Zanucco, E.; Knyazev, P.; Ullrich, A.: Erk2 but not Erk1 regulates crosstalk between Met and EGFR in squamous cell carcinoma cell lines. MOLECULAR CANCER 14, 54 (2015)

Ataseven, B.; Gunesch, A.; Eiermann, W.; Kates, R. E.; Hoegel, B.; Knyazev, P.; Ullrich, A.; Harbeck, N.: PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs. ONCOTARGETS AND THERAPY 7, S. 1723 - 1731 (2014)

Gärtner, S.; Gunesch, A.; Knyazeva, T.; Wolf, P.; Högel, B.; Eiermann, W.; Ullrich, A.; Knyazev, P.; Ataseven, B.: PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement. PLOS ONE 9 (1), e84472 (2014)

Kopp, F.; Hermawan, A.; Oak, P. S.; Ulaganathan, V. K.; Herrmann, A.; Elnikhely, N.; Thakur, C.; Xiao, Z.; Knyazev, P.; Ataseven, B. et al.; Savai, R.; Wagner, E.; Roidl, A.: Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells. TRANSLATIONAL ONCOLOGY 7 (6), S. 702 - 711 (2014)

Xiao, Z.; Sperl, B.; Ullrich, A.; Knyazev, P.: Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status. ONCOTARGET 5 (24), S. 12877 - 12890 (2014)

Ataseven, B.; Angerer, R.; Kates, R.; Gunesch, A.; Knyazev, P.; Hoegel, B.; Becker, C.; Eiermann, W.; Harbeck, N.: PTK7 Expression in Triple-negative Breast Cancer. ANTICANCER RESEARCH 33 (9), S. 3759 - 3763 (2013)

Vlaicu, P.; Mertins, P.; Mayr, T.; Widschwendter, P.; Ataseven, B.; Hogel, B.; Eiermann, W.; Knyazev, P.; Ullrich, A.: Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator. BMC CANCER 13, 197 (2013)

Oak, P. S.; Kopp, F.; Thakur, C.; Ellwart, J. W.; Rapp, U. R.; Ullrich, A.; Wagner, E.; Knyazev, P.; Roidl, A.: Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells. INTERNATIONAL JOURNAL OF CANCER 131 (12), S. 2808 - 2819 (2012)

Reinhard, J.; Horvat-Bröcker, A.; Illes, S.; Zaremba, A.; Knyazev, P.; Ullrich, A.; Faissner, A.: Protein tyrosine phosphatases expression during development of mouse superior colliculus. Experimental Brain Research 199 (3-4 Sp. Iss.), S. 279 - 297 (2009)

Feng, X.; Lu, X.; Man, X.; Zhou, W.; Jiang, L. Q.; Knyazev, P.; Lei, L.; Huang, Q.; Ullrich, A.; Zhang, Z. et al.; Chen, Z.: Overexpression of Csk-binding protein contributes to renal cell carcinogenesis. Oncogene 28 (37), S. 3320 - 3331 (2009)

Roidl, A.; Berger, H. J.; Kumar, S.; Bange, J.; Knyazev, P.; Ullrich, A.: Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation. Clinical Cancer Research 15 (6), S. 2058 - 2066 (2009)

Singh, B.; Schneider, M.; Knyazev, P.; Ullrich, A.: UV-induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell lines. International Journal of Cancer 124 [2009] (3), S. 531 - 539 (2008)

Lodygin, D.; Tarasov, V.; Epanchintsev, A.; Berking, C.; Knyazeva, T.; Körner, H.; Knyazev, P.; Diebold, J.; Hermeking, H.: Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7 (16), S. 2591 - 2600 (2008)

Reschke, M.; Mihic-Probst, D.; van der Horst, E. H.; Knyazev, P.; Wild, P. J.; Hutterer, M.; Meyer, S.; Dummer, R.; Moch, H.; Ullrich, A.: HER3 is a determinant for poor prognosis in melanoma. Clinical Cancer Research 14 (16), S. 5188 - 5197 (2008)

Horvat-Bröcker, A.; Reinhard, J.; Illes, S.; Paech, T.; Zoidl, G.; Harroch, S.; Distler, C.; Knyazev, P.; Ullrich, A.; Faissner, A.: RECEPTOR PROTEIN TYROSINE PHOSPHATASES ARE EXPRESSED BY CYCLING RETINAL PROGENITOR CELLS AND INVOLVED IN NEURONAL DEVELOPMENT OF MOUSE RETINA. Neuroscience 152 (3), S. 618 - 645 (2008)

Hutterer, M.; Knyazev, P.; Abate, A.; Reschke, M.; Maier, H.; Stefanova, N.; Knyazeva, T.; Barbieri, V.; Reindl, M.; Muigg, A. et al.; Kostron, H.; Stockhammer, G.; Ullrich, A.: Axl and growth arrest - Specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clinical Cancer Research 14 (1), S. 130 - 138 (2008)

Ruhe, J. E.; Streit, S.; Hart, S.; Wong, C. H.; Specht, K.; Knyazev, P.; Knyazeva, T.; Tay, L. S.; Loo, H. L.; Foo, P. et al.; Wong, W.; Pok, S.; Lim, S. J.; Ong, H.; Luo, M.; Ho, H. V.; Peng, K.; Lee, T. C.; Bezler, M.; Mann, C.; Gaertner, S.; Hoefler, H.; Iacobelli, S.; Peter, S.; Tay, A.; Brenner, S.; Venkatesh, B.; Ullrich, A.: Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines. Cancer Research 67 (23), S. 11368 - 11376 (2007)

Abate, A.; Hutterer, M.; Mair, H.; Stefanova, N.; Kostron, H.; Knyazev, P.; Ullrich, A.; Stockhammer, G.: The receptor tyrosine kinase Axl is widely expressed in gliomas of various histology. Neuro-Oncology 8 (4), S. 321 - 322 (2006)